CDKN2C Antikörper (AA 101-168) (Cy7)

Produktnummer ABIN706187

Der Kaninchen Polyklonal anti-CDKN2C Antikörper wird verwendet zum Nachweis von CDKN2C in Proben von Human. Er wurde validiert für WB, IF (cc) und IF (p).

Kurzübersicht für CDKN2C Antikörper (AA 101-168) (Cy7) (ABIN706187)

Target: CDKN2C (Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CDKN2C Antikörper ist konjugiert mit Cy7

Applikation: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Produktdetails anti-CDKN2C Antikörper (Cy7)

Bindungsspezifität: AA 101-168

Homologie: Human,Mouse,Rat,Dog,Horse

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human CDKN2C

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Haltbarkeit: 12 months

Details zu CDKN2C

Target: CDKN2C (Cyclin-Dependent Kinase Inhibitor 2C (p18, Inhibits CDK4) (CDKN2C))

Andere Bezeichnung: CDKN2C

Hintergrund:

Synonyms: CDK6 inhibitor p18, CDKN 2C, CDKN 6, CDKN2C, CDKN6, CDN2C_HUMAN, Cyclin dependent inhibitor, Cyclin dependent kinase 4 inhibitor C, Cyclin dependent kinase 6 inhibitor, Cyclin dependent kinase 6 inhibitor p18, Cyclin dependent kinase inhibitor 2C p18 inhibits CDK4, Cyclin dependent kinase inhibitor 2C, Cyclin-dependent kinase 4 inhibitor C, Cyclin-dependent kinase 6 inhibitor, INK4C, OTTHUMP00000046546, p18, p18 inhibits CDK4, p18 INK4C, p18 INK6, p18-INK4C, p18-INK6.

Background: p18 INK4C is a specific inhibitor of cdk4 / cdk6 (it interacts strongly with CDK6 and weakly with CDK4), and is expressed during G1 to S transition in the eukaryotic cell division cycle. It is maximally induced as cells enter S phase. Highest expression levels are found in skeletal muscle, but it is also found in the pancreas and heart.

Gen-ID: 1031

Pathways: Zellzyklus, Mitotic G1-G1/S Phases